TrialThe Pediatric infectious disease journal2017

Safety, Efficacy, and Exposure-Response of Voriconazole in Pediatric Patients With Invasive Aspergillosis, Invasive Candidiasis or Esophageal Candidiasis.

Judith M Martin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.